Literature DB >> 5636556

Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.

L J Old, E Stockert, E A Boyse, J H Kim.   

Abstract

Antigenic modulation (the loss of TL antigens from TL+ cells exposed to TL antibody in the absence of lytic complement) has been demonstrated in vitro. An ascites leukemia, phenotype TL.1,2,3, which modulates rapidly and completely when incubated with TL antiserum in vitro, was selected for further study of the phenomenon. Over a wide range of TL antibody concentrations modulation at 37 degrees C was detectable within 10 min and was complete within approximately 1 hr. The cells were initially sensitized to C' by their contact with antibody, thereafter losing this sensitivity to C' lysis together with their sensitivity to TL antibody and C' in the cytotoxic test. The capacity of the cells to undergo modulation was abolished by actinomycin D and by iodoacetamide, and by reducing the temperature of incubation to 0 degrees C. Thus modulation apparently is an active cellular process. Antigens TL. 1,2, and 3 are all modulated by anti-TL.1,3 serum and by anti-TL.3 serum. This modulation affects all three TL components together, even when antibody to one or two of them is lacking. aAnti-TL.2 serum does not induce modulation and in fact impairs modulation by the other TL antibodies. The influence of the TL phenotype of cells upon the demonstrable content of H-2 (D region) isoantigen, first shown in cells modulated in vivo, has been observed with cells modulated in vitro. Cells undergoing modulation show a progressive increase in H-2 (D region) antigen over a period of 4 hr, with no change in H-2 antigens of the K region. Restoration of the TL+ phenotype of modulated cells after removal of antibody is less rapid than TL+ --> TL- modulation and may require several cell divisions.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5636556      PMCID: PMC2138467          DOI: 10.1084/jem.127.3.523

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  GENETIC DETERMINATION OF THE TL (THYMUSLEUKAEMIA) ANTIGEN IN THE MOUSE.

Authors:  E A BOYSE; L J OLD; S LUELL
Journal:  Nature       Date:  1964-02-22       Impact factor: 49.962

2.  Some further data on cytotoxic isoantibodies in the mouse.

Authors:  E A BOYSE; L J OLD; E STOCKERT
Journal:  Ann N Y Acad Sci       Date:  1962-10-24       Impact factor: 5.691

3.  ANTIGENIC PROPERTIES OF EXPERIMENTAL LEUKEMIAS. I. SEROLOGICAL STUDIES IN VITRO WITH SPONTANEOUS AND RADIATION-INDUCED LEUKEMIAS.

Authors:  L J OLD; E A BOYSE
Journal:  J Natl Cancer Inst       Date:  1963-10       Impact factor: 13.506

4.  Thymus cells of radiation-chimeras: TL phenotype, sensitivity to guinea-pig serum, and origin from donor cells.

Authors:  M Schlesinger; E A Boyse; L J Old
Journal:  Nature       Date:  1965-06-12       Impact factor: 49.962

5.  Heterogeneity in biologic functions of antibodies: implications for immunologic tumor enhancement.

Authors:  K J Bloch
Journal:  Fed Proc       Date:  1965 Sep-Oct

6.  Mouse isoantigens: separation of soluble TL (thymus-leukemia) antigen from soluble H-2 histocompatibility antigen by column chromatography.

Authors:  D A Davies; E A Boyse; L J Old; E Stockert
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307

  6 in total
  75 in total

1.  Ontogeny of murine B lymphocytes: sequence of B-cell differentiation from surface-immunoglobulin-negative precursors to plasma cells.

Authors:  U Hämmerling; A F Chin; J Abbott
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

2.  Neutralizing anti-gH antibody of Varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency.

Authors:  Kimiyasu Shiraki; Tohru Daikoku; Masaya Takemoto; Yoshihiro Yoshida; Kazuhiro Suzuki; Yasushi Akahori; Toshiomi Okuno; Yoshikazu Kurosawa; Yoshizo Asano
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

Review 3.  The significance of biological heterogeneity.

Authors:  H Rubin
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

4.  Somatic hybrid of thymus leukemia (.

Authors:  W Liang; E P Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

5.  Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation.

Authors:  W Parker; Z E Holzknecht; A Song; B A Blocher; M Bustos; K J Reissner; M L Everett; J L Platt
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

6.  Modulation of mouse mammary tumor virus production in the MJY-alpha cell line.

Authors:  M J Yagi; P B Blair; M A Lane
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

7.  Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.

Authors:  O Merimsky; Y Shoenfeld; G Yecheskel; S Chaitchik; E Azizi; P Fishman
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

8.  Antigenic modulation and turnover in human neutrophils.

Authors:  S A Weitzman; M C Desmond; T P Stossel
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

9.  Persistence of infectious Friend virus in spleens of mice after spontaneous recovery from virus-induced erythroleukemia.

Authors:  B Chesebro; M Bloom; K Wehrly; J Nishio
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

10.  Tumour cell-antibody interactions. II. In vitro studies.

Authors:  G Froese; I Berczi; L G Israels
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.